Archives

  • Lupin launches Moxifloxacin Ophthalmic Solution USP 0.5%

    • February 15, 2020
    • Posted By : Peeyush Jaiswal
    • 0 Comment

    Lupin announced the launch of Moxifloxacin Ophthalmic Solution USP, 0.5%, having received an approval from the United States Food and

    Read More
  • Drug marketers to be held responsible for quality

    • February 15, 2020
    • Posted By : Peeyush Jaiswal
    • 0 Comment

    Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product

    Read More
  • FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer

    • February 15, 2020
    • Posted By : Peeyush Jaiswal
    • 0 Comment

    Roche today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq® (atezolizumab), in combination with carboplatin and etoposide

    Read More
  • Carbiotix Launches Second Generation Diagnostic Platform

    • February 12, 2020
    • Posted By : Peeyush Jaiswal
    • 0 Comment

    Carbiotix (publ) (“Carbiotix”) announces today that the company has launched its second generation diagnostic platform for gut health based on

    Read More
  • FDA Grants Priority Review to Capmatinib in METex14+ NSCLC

    • February 12, 2020
    • Posted By : Peeyush Jaiswal
    • 0 Comment

    The FDA approved and granted a priority review to the new drug application (NDA) for capmatinib (INC280), according to Novartis,

    Read More

Archive

Offers